Literature DB >> 12782533

Emergency medicine animal research: does use of randomization and blinding affect the results?

Vik Bebarta1, Dylan Luyten, Kennon Heard.   

Abstract

OBJECTIVES: It has been shown that human clinical trials that lack randomization (RND) or blinding (BLD) often overestimate the magnitude of treatment effects. However, no studies have evaluated the effect of RND and BLD on animal research. The authors' objectives were to determine the proportion of animal studies presented at a national academic emergency medicine meeting that utilize randomization, blinding, or both; and to determine whether failure to employ these techniques changes the likelihood of observing a difference between treatment groups.
METHODS: Two trained researchers reviewed abstracts presented at the 1997-2001 Society for Academic Emergency Medicine (SAEM) annual meetings using a standard data collection sheet. Studies that used an animal or cell line, compared two or more study groups, and measured an effect caused by the intervention or drugs were included. Studies were classified as randomized (RND+) if any part of the experiment involved random assignment of subjects to treatment groups, blinded (BLD+) if any assessment of the outcome was made by an investigator blinded to treatment group, and outcome-positive (Outcome+) if any difference between the study groups met the author's definition of significant. Following the initial review, differences in classification were resolved by consensus. The association between outcome and study methodology (RND, BLD or both) was measured using odds ratios (ORs) with 95% confidence intervals (95% CIs).
RESULTS: A total of 2,592 studies were published as abstracts. Three hundred eighty-nine were animal studies, and 290 of these studies had two or more study groups. RND- and BLD- studies were more likely to be Outcome+ than RND+ or BLD+ studies (OR = 3.4; 95% CI = 1.7 to 6.9 and OR = 3.2; 95% CI = 1.3 to 7.7, respectively). When studies that used both RND and BND were compared with studies that used neither, the OR for a positive study was 5.2 (95% CI = 2.0 to 13.5).
CONCLUSIONS: These results suggest that animal studies that do not utilize RND and BLD are more likely to report a difference between study groups than studies that employ these methods.

Entities:  

Mesh:

Year:  2003        PMID: 12782533     DOI: 10.1111/j.1553-2712.2003.tb00056.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  87 in total

Review 1.  Where is the evidence that animal research benefits humans?

Authors:  Pandora Pound; Shah Ebrahim; Peter Sandercock; Michael B Bracken; Ian Roberts
Journal:  BMJ       Date:  2004-02-28

Review 2.  A systematic review of exercise training to promote locomotor recovery in animal models of spinal cord injury.

Authors:  Camila R Battistuzzo; Robert J Callister; Robin Callister; Mary P Galea
Journal:  J Neurotrauma       Date:  2012-04-18       Impact factor: 5.269

3.  Extending clinical equipoise to phase 1 trials involving patients: unresolved problems.

Authors:  James A Anderson; Jonathan Kimmelman
Journal:  Kennedy Inst Ethics J       Date:  2010-03

Review 4.  The relationship between study sponsorship, risks of bias, and research outcomes in atrazine exposure studies conducted in non-human animals: Systematic review and meta-analysis.

Authors:  L Bero; A Anglemyer; H Vesterinen; D Krauth
Journal:  Environ Int       Date:  2015-12-13       Impact factor: 9.621

Review 5.  Neuroprotective Effect of Natural Products on Peripheral Nerve Degeneration: A Systematic Review.

Authors:  Heitor G Araújo-Filho; Lucindo J Quintans-Júnior; André S Barreto; Jackson R G S Almeida; Rosana S S Barreto; Jullyana S S Quintans
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

6.  Rethinking risk assessment for emerging technology first-in-human trials.

Authors:  Anna Genske; Sabrina Engel-Glatter
Journal:  Med Health Care Philos       Date:  2016-03

Review 7.  Methodological quality of animal studies on neuroprotection in focal cerebral ischaemia.

Authors:  H Bart van der Worp; Peter de Haan; Erik Morrema; Cor J Kalkman
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

8.  Translating animal research into clinical benefit.

Authors:  Daniel G Hackam
Journal:  BMJ       Date:  2007-01-27

9.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 10.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.